Trial Profile
Prognostic significance of microRNA expression in completely resected lung adenocarcinoma and the associated response to erlotinib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary)
- Indications Adenocarcinoma; Lung cancer
- Focus Therapeutic Use
- 01 Dec 2015 New trial record